Full-text search

Results for “Sandoz Pharmaceutical”

Search across the indexed text of every released document.

61 documents found

Times Square Tower
document TEXT-001-HOUSE_OVERSIGHT_024003.txt House Oversight Committee — Epstein Estate Records (Nov 2025)

…ignments with clients in the pharmaceutical, biotech and insurance industry. Previously, Philippe was an executive with Sandoz Pharmaceutical for seven years, where he built and led an organization responsible for late stage clinical project management, portfolio management, and...

Text 001 House Oversight 028413
document TEXT-001-HOUSE_OVERSIGHT_028413.txt House Oversight Committee — Epstein Estate Records (Nov 2025)

{"componentLayouts":{"ComponentLayout-1":{"columnRange":{"length":8,"start":0},"contentInset":{"bottom":false,"left":true,"right":true,"top":false},"identifier":"ComponentLayout-1","ignoreDocumentMargin":"both","margin":{"bottom":"25.0pt","top":"0.0pt"}},"ComponentLayout-10":{"c...

2014 at a groundbreaking ceremony in Summit, N.J., for Celgene, the pharmaceutical
document IMAGES-009-HOUSE_OVERSIGHT_028415.txt House Oversight Committee — Epstein Estate Records (Nov 2025)

2014 at a groundbreaking ceremony in Summit, N.J., for Celgene, the pharmaceutical company he led until stepping down to run for United States Senate. To his right are Representative Leonard Lance of New Jersey and former Gov. Chris Christie. Mel Evans/Associated Press"},"identi...

NLV-III will be managed by the New Leaf team, which currently manages NLV-I, NLV-IL, and
document IMAGES-007-HOUSE_OVERSIGHT_024022.txt House Oversight Committee — Epstein Estate Records (Nov 2025)

…ignments with clients in the pharmaceutical, biotech and insurance industry. Previously, Philippe was an executive with Sandoz Pharmaceutical for seven years, where he built and led an organization responsible for late stage clinical project management, portfolio management, and...

EvENING OF AuGusT 22, 2012 1:30 p.m. the Third Place: Healthcare Everywhere
document IMAGES-004-HOUSE_OVERSIGHT_017525.txt Aug 22, 2012 House Oversight Committee — Epstein Estate Records (Nov 2025)

Program EvENING OF AuGusT 22, 2012 1:30 p.m. the Third Place: Healthcare Everywhere HoTeitt KuncG Cari_ BANQUET Patrick Flochel, Global Pharmaceutical Leader, Ernst & Young 6:00 p.m. Welcoming Reception Special Recognition to 1:45 p.m. The Asian Diabetes Etidemit Dr. Laurent Lek...

For example, a pharmaceutical company used chari
document IMAGES-007-HOUSE_OVERSIGHT_022519.txt House Oversight Committee — Epstein Estate Records (Nov 2025)

For example, a pharmaceutical company used chari- table donations to a small local castle restoration charity headed by a foreign government official to induce the offi- cial to direct business to the company. Although the charity was a bona fide charitable organization, internal...

COLLABORATIVE INSIGHTS February 25, 2019
document IMAGES-008-HOUSE_OVERSIGHT_024897.txt Feb 25, 2019 House Oversight Committee — Epstein Estate Records (Nov 2025)

COWEN COLLABORATIVE INSIGHTS February 25, 2019 beverages) will be imperative. This regulatory framework does not affect skincare, cosmetics or topicals with CBD or hemp ingredients. 2 Europe UK The UK legalized prescription based medical cannabis in November 2018. Medical can...

prescription drug costs during the temporary “gap” from Medicare coverage until their
document IMAGES-007-HOUSE_OVERSIGHT_024072.txt House Oversight Committee — Epstein Estate Records (Nov 2025)

prescription drug costs during the temporary “gap” from Medicare coverage until their prescription drug costs reach the threshold for catastrophic coverage by Medicare), (iii) an approval process for generic biologics and granting exclusive marketing rights to original manufactur...

There may be significant delays in obtaining reimbursement for newly approved drugs, and
document IMAGES-007-HOUSE_OVERSIGHT_024071.txt House Oversight Committee — Epstein Estate Records (Nov 2025)

There may be significant delays in obtaining reimbursement for newly approved drugs, and coverage may be more limited than the purposes for which the drug is approved by the FDA or similar regulatory authorities outside the United States. Moreover, eligibility for reimbursement d...

Leadership: NLV_ are leaders in biopharmaceutical investing across all stages and transaction
document IMAGES-007-HOUSE_OVERSIGHT_024045.txt House Oversight Committee — Epstein Estate Records (Nov 2025)

Leadership: NLV_ are leaders in biopharmaceutical investing across all stages and transaction types The New Leaf team is well positioned to continue to play a leadership role in the sector. Over the last two decades, the Fund Managers have demonstrated an ability to access high...

in thousands of blogs and other written forums and converts this unstructured content
document IMAGES-007-HOUSE_OVERSIGHT_024051.txt House Oversight Committee — Epstein Estate Records (Nov 2025)

in thousands of blogs and other written forums and converts this unstructured content into structured information to support better-informed decision making by patients, providers, and pharmaceutical marketing teams. e Investment Theme - Patient Engagement / Shift to Low-Cost Se...

molecular immunology at The Pasteur Institute and earned an M.D. and Ph.D. from the
document IMAGES-007-HOUSE_OVERSIGHT_024023.txt House Oversight Committee — Epstein Estate Records (Nov 2025)

molecular immunology at The Pasteur Institute and earned an M.D. and Ph.D. from the University of Paris, and an M.B.A. from Columbia University. Jeani Delagardelle, (57), Managing Director, helped found New Leaf in 2005. She joined Sprout in 2000. At New Leaf, Jeani leads the Me...